133 related articles for article (PubMed ID: 37598335)
41. Comparison of five methods for concentrating progenitor cells in human marrow transplantation.
Dragani A; Angelini A; Iacone A; D'Antonio D; Torlontano G
Blut; 1990 May; 60(5):278-81. PubMed ID: 2350590
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
[TBL] [Abstract][Full Text] [Related]
43. A double buffy coat method for red cell removal from ABO-incompatible marrow.
Rosenfeld CS; Tedrow H; Boegel F; Gremba C; Shadduck RK
Transfusion; 1989 Jun; 29(5):415-7. PubMed ID: 2660336
[TBL] [Abstract][Full Text] [Related]
44. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
[No Abstract] [Full Text] [Related]
45. Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts.
Rowley S; Davis J; Braine H; Jones R; Yeager A; Saral R; Santos G
Prog Clin Biol Res; 1990; 333():369-77. PubMed ID: 2308991
[TBL] [Abstract][Full Text] [Related]
46. Optimal processing of human umbilical cord blood for clinical banking.
Denning-Kendall P; Donaldson C; Nicol A; Bradley B; Hows J
Exp Hematol; 1996 Oct; 24(12):1394-401. PubMed ID: 8913285
[TBL] [Abstract][Full Text] [Related]
47. Recovery of hematopoiesis after blood-group-incompatible bone marrow transplantation with red-blood-cell-depleted grafts.
Falkenburg JH; Schaafsma MR; Jansen J; Brand A; Goselink HM; Zwaan FE; Eernisse JG
Transplantation; 1985 May; 39(5):514-20. PubMed ID: 3887691
[TBL] [Abstract][Full Text] [Related]
48. ABO incompatibile graft management in pediatric transplantation.
Balduzzi A; Bönig H; Jarisch A; Nava T; Ansari M; Cattoni A; Prunotto G; Lucchini G; Krivan G; Matic T; Kalwak K; Yesilipek A; Ifversen M; Svec P; Buechner J; Vettenranta K; Meisel R; Lawitschka A; Peters C; Gibson B; Dalissier A; Corbacioglu S; Willasch A; Dalle JH; Bader P;
Bone Marrow Transplant; 2021 Jan; 56(1):84-90. PubMed ID: 32594103
[TBL] [Abstract][Full Text] [Related]
49. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
50. Allogeneic bone marrow transplantation from a major ABO-incompatible donor. Infusion of hemopoietic stem cells isolated by Ficoll-Hypaque method.
Harada M; Aoyagi N; Kondo K; Ishino C; Odaka K; Matsue K; Yoshida T; Hattori K
Transplantation; 1983 Feb; 35(2):191-2. PubMed ID: 6131551
[No Abstract] [Full Text] [Related]
51. Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products.
Avecilla ST; Marionneaux SM; Leiva TD; Tonon JA; Chan VT; Moung C; Meagher RC; Maslak P
Transfusion; 2016 Feb; 56(2):528-32. PubMed ID: 26395285
[TBL] [Abstract][Full Text] [Related]
52. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax.
Aktas M; Radke TF; Strauer BE; Wernet P; Kogler G
Cytotherapy; 2008; 10(2):203-11. PubMed ID: 18368599
[TBL] [Abstract][Full Text] [Related]
53. Density separation and cryopreservation of umbilical cord blood cells: evaluation of recovery in short-and long-term cultures.
Almici C; Carlo-Stella C; Wagner JE; Rizzoli V
Acta Haematol; 1996; 95(3-4):171-5. PubMed ID: 8677738
[TBL] [Abstract][Full Text] [Related]
54. Equine bone marrow volume reduction, red blood cell depletion, and mononuclear cell recovery using the PrepaCyte-CB processing system.
Burton AG; Clark KC; Borjesson DL; Carrade DD; Burges J; Owens SD
Vet Clin Pathol; 2015 Jun; 44(2):188-93. PubMed ID: 25627833
[TBL] [Abstract][Full Text] [Related]
55. Bone marrow processing using the fenwal CS-3000 plus blood cell separator: results of 99 procedures.
González-Campos J; Carmona-González M; Rodríguez-Fernández JM; Mellado-Damas N; de Luís-Navarro J
J Hematother Stem Cell Res; 2000 Feb; 9(1):83-8. PubMed ID: 10738975
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow fractionation by the haemonetics system: reduction of red cell mass before marrow freezing, with special reference to pediatric marrow volumes.
Saarinen UM; Lähteenoja KM; Juvonen E
Vox Sang; 1992; 63(1):16-22. PubMed ID: 1413659
[TBL] [Abstract][Full Text] [Related]
57. Highly purified CD34-positive cells reconstitute hematopoiesis.
Civin CI; Trischmann T; Kadan NS; Davis J; Noga S; Cohen K; Duffy B; Groenewegen I; Wiley J; Law P; Hardwick A; Oldham F; Gee A
J Clin Oncol; 1996 Aug; 14(8):2224-33. PubMed ID: 8708711
[TBL] [Abstract][Full Text] [Related]
58. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow processing on the Haemonetics V50 cell separator.
Anderson NA; Cornish JM; Godwin V; Gunstone MJ; Oakhill A; Pamphilon DH
Transfus Sci; 1990; 11(2):201-4. PubMed ID: 10149526
[TBL] [Abstract][Full Text] [Related]
60. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
